![](/wp-content/uploads/2018/10/s88muvmRACfKSOYmpVeH.png)
$599
Sanofi Pursuing U200 Lispro; New Ph1 Study
Sanofi has initiated a new Ph1 trial evaluating a U200 concentration of its bs-lispro. Below, FENIX provides thoughts on why Sanofi is pursuing U200 Admelog including its likely use in the pre-filled patch pump that is being developed in partnership with Verily and Sensile Medical.